Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study

被引：0
|
作者：
Gerd Koehler
Simon Heller
Stefan Korsatko
Carsten Roepstorff
Søren Rasmussen
Hanne Haahr
Thomas R. Pieber
机构：
[1] Medical University Graz,Division of Endocrinology and Metabolism, Department of Internal Medicine
[2] University of Sheffield,Academic Unit of Diabetes, Endocrinology and Metabolism, School of Medicine and Biomedical Sciences
[3] Novo Nordisk,undefined
来源：
Diabetologia | 2014年 / 57卷
关键词：
Counter-regulation; Degludec; Glargine; Hormones; Hypoglycaemia; Type 1 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：40 / 49
页数：9
相关论文
共 50 条
  • [1] Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study
    Koehler, Gerd
    Heller, Simon
    Korsatko, Stefan
    Roepstorff, Carsten
    Rasmussen, Soren
    Haahr, Hanne
    Pieber, Thomas R.
    DIABETOLOGIA, 2014, 57 (01) : 40 - 49
  • [2] SWITCH 1: reduced risk of hypoglycaemia with insulin degludec vs insulin glargine U100 in patients with type 1 diabetes: a randomised, double-blind, crossover trial
    Lane, W.
    Bailey, T. S.
    Gerety, G.
    Gumprecht, J.
    Philis-Tsimikas, A.
    Hansen, C. T.
    Nielsen, T. S. S.
    Warren, M. L.
    DIABETOLOGIA, 2016, 59 : S42 - S43
  • [3] SWITCH 1: Reduced risk of hypoglycaemia with insulin degludec vs insulin glargine U100 in patients with type 1 diabetes-a randomised, double-blind, crossover trial
    Lane, Wendy
    Bailey, Timothy S.
    Gerety, Gregg
    Gumprecht, Janusz
    Philis-Tsimikas, Athena
    Hansen, Charlotte T.
    Nielsen, Thor Schutt Svane
    Warren, Mark L.
    Fulcher, Gregory R.
    CLINICAL ENDOCRINOLOGY, 2018, 89 : 9 - 9
  • [4] Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes
    Heller, SR
    Colagiuri, S
    Vaaler, S
    Wolffenbuttel, BHR
    Koelendorf, K
    Friberg, HH
    Windfeld, K
    Lindholm, A
    DIABETIC MEDICINE, 2004, 21 (07) : 769 - 775
  • [5] SWITCH 2: reduced risk of hypoglycaemia with insulin degludec vs insulin glargine U100 in a type 2 diabetes population on basal insulin: a randomised, double-blind, crossover trial
    Wysham, C.
    Bhargava, A.
    Chaykin, L. B.
    de la Rosa, R.
    Handelsman, Y.
    Troelsen, L. N.
    Kvist, K.
    Norwood, P.
    DIABETOLOGIA, 2016, 59 : S43 - S44
  • [6] Reduced nocturnal hypoglycaemia with insulin degludec as compared to insulin glargine: results of a 2-year randomised trial in type 2 diabetes
    Rodbard, H. W.
    Zinman, B.
    Cariou, B.
    Philis-Tsimikas, A.
    Handelsman, Y.
    Skjoth, T. V.
    Chu, P. -L.
    Mathieu, C.
    DIABETOLOGIA, 2012, 55 : S378 - S378
  • [7] A two year randomised trial: improved glycaemic control and lower risk of nocturnal hypoglycaemia with insulin degludec compared with insulin glargine in Type 1 diabetes
    Russell-Jones, D. L.
    Heller, S.
    Hansen, C. T.
    Chang, D.
    Bode, B.
    DIABETIC MEDICINE, 2013, 30 : 74 - 74
  • [8] Daily blood glucose profiles in subjects with type 2 diabetes in a randomised, crossover, double-blind comparison of insulin detemir and insulin glargine
    King, A.
    DIABETOLOGIA, 2008, 51 : S401 - S401
  • [9] Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes
    Home, P. D.
    Meneghini, L.
    Wendisch, U.
    Ratner, R. E.
    Johansen, T.
    Christensen, T. E.
    Jendle, J.
    Roberts, A. P.
    Birkeland, K. I.
    DIABETIC MEDICINE, 2012, 29 (06) : 716 - 720
  • [10] A Randomized Crossover Study of the Efficacy and Safety of Switching from Insulin Glargine to Insulin Degludec in Children with Type 1 Diabetes
    Urakami, Tatsuhiko
    Mine, Yusuke
    Kuwabara, Remi
    Aoki, Masako
    Okuno, Misako
    Suzuki, Junichi
    DIABETES, 2015, 64 : A366 - A366
12345